“A 50-mg dose of Enbrel now costs patients $7,401.83 per month: 643% more than it cost when launched in 1998,” according to the allegations in the antitrust class action filed against Enbrel manufacturer Amgen Inc.
August 09, 2024 at 01:59 PM
3 minute read
A new lawsuit accuses Amgen Inc. of preventing competition and maintaining monopoly prices with its blockbuster Enbrel prescription drug for treating adults with rheumatoid arthritis.
Glasser and Glasser, Hagens Berman Sobol Shapiro and Lowey Dannenberg filed the antitrust class action Tuesday on behalf of two nonprofit corporations doing business as CareFirst BlueCross BlueShield.
Presented by BigVoodoo
The National Law Journal honors attorneys & judges who've made a remarkable difference in the legal profession in the D.C. area.
The New York Law Journal honors attorneys and judges who have made a remarkable difference in the legal profession in New York.
The African Legal Awards recognise exceptional achievement within Africa s legal community during a period of rapid change.
Description: Fox Rothschild has an opening in the Atlantic City, NJ office for a litigation associate to join a fast-paced, national litigat...
Our client, a litigation services boutique, is seeking to add a Coverage & Commercial Litigation Attorney to support their rapidly growi...
Cicchiello & Cicchiello, LLP - Hartford Law Firm seeking to hire an Associate Attorney. We focus our practice primarily on Personal Inju...
Breaking news and trends for law firm and legal departments about the evolving federal regulations in a volatile political climate.
Amgen sign at its headquarters in Thousand Oaks, California, USA. Amgen Inc. is an American biopharmaceutical company. Credit: JHVEPhoto/Adobe Stock
